Lung volume reduction surgery: an analysis of hospital costs

Chest
E H ElpernS Kesten

Abstract

Lung volume reduction surgery (LVRS) represents a potential breakthrough in the management of advanced emphysema, although questions remain about clinical and economic implications of widespread application of LVRS. In this report, we describe hospital costs, excluding physicians' fees, for LVRS. Hospital charges were obtained from billing records and converted to costs by applying multiple cost-to-charge ratios. A large, urban academic medical center. Fifty-two consecutive patients who received bilateral LVRS through a median sternotomy between April 1995 and August 1996. Median hospital stay was 10 days (mean= 14.8+/-12.8 days; range=3 to 48 days), including 2 days (mean=6+/-9.2 days; range=1 to 35 days) in the ICU. One hospital death occurred. Hospital costs per case ranged from $11,712 to $121,829, with mean costs of $30,976 and median costs of $19,771. Costs were related significantly to duration of ICU stay and length of hospitalization. Patients who accrued the highest costs were significantly older than the remainder of the sample (69.3 years vs 62.4 years). Hospital costs of LVRS vary significantly but are related directly to hospital stay. Identification of factors associated with prolonged stays can be used in assess...Continue Reading

References

Jan 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·J D CooperC L Roper
Apr 25, 1996·The New England Journal of Medicine·F C SciurbaR J Landreneau
Apr 1, 1996·American Journal of Respiratory and Critical Care Medicine·J D Cooper, S S Lefrak
Apr 1, 1996·American Journal of Respiratory and Critical Care Medicine·B J Make, A M Fein
May 1, 1996·The Annals of Thoracic Surgery·J I MillerK A Mansour
Oct 1, 1996·Chest·R K AlbertJ O Benditt
Nov 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·J D CooperS S Lefrak
Dec 1, 1996·American Journal of Respiratory and Critical Care Medicine·G G Weinmann, R Hyatt

❮ Previous
Next ❯

Citations

Feb 16, 2000·Chest·S D SullivanT A Lee
Feb 28, 2002·Expert Opinion on Pharmacotherapy·Michele A Faulkner, Daniel E Hilleman
Feb 24, 2001·Clinics in Chest Medicine·L L Schulman
May 17, 2000·Current Opinion in Pulmonary Medicine·S A Strassels
Jun 1, 2000·Australian and New Zealand Journal of Medicine·S H PorterS Homan
Oct 4, 2006·Current Opinion in Anaesthesiology·B Mets
Dec 1, 2003·Expert Review of Pharmacoeconomics & Outcomes Research·Anna ReedGregory Snell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Medical Journal of Australia
G I SnellJ A Smith
Zhonghua wai ke za zhi [Chinese journal of surgery]
J Liu, F Varoli
Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Yi ShenLi Yuan
© 2022 Meta ULC. All rights reserved